News

Home / News

Announcement of the BOD's approval regarding the participation in cash injection of Chuang Yi Biotech Co., Ltd.

2023.11.2

...

More

TSH Board of Directors Approved Financial Statements For the Nine Months Ended September 30, 2023

2023.11.2

...

More

TSH Biopharm was invited to attend the institutional investor conference hosted by Concord Securities

2023.9.6

...

More

TSH Board of Directors Approved Financial Statements For the Six Months Ended June 30, 2023

2023.8.14

...

More

Expand New Therapeutic Area in Chronic Disease, TSH Entering Ophthalmic Market

2023.7.13

...

More

TSH Board of Directors resolved to convene the 2023 Annual General Shareholders' Meeting

2023.2.24

...

More